Abu Dhabi, April 10 -- Burjeel Medical City, the flagship facility of Burjeel Holdings, has launched a state-of-the-art Epilepsy Monitoring Unit (EMU) within its Neuroscience Institute, further advancing its mission to provide comprehensive and specialized care for individuals affected by this neurological condition. As one of the few dedicated units of its kind in the UAE, the EMU is set to strengthen epilepsy diagnosis and management across the country.

The unit was launched in the presence of Dr. Mujtaba Ali Khan, CEO of BMC, and Dr. Mohammad Fityan, Chief Medical Officer of BMC.

"Epilepsy affects millions of people worldwide, with profound impacts on patients and their families. The launch of our Epilepsy Monitoring Unit is a signif...